Compounds and methods for the diagnosis and treatment of ehrlichia infection
CA 2284251 A1 · Owner: Reed, Steven G. · Inventors: Houghton, Raymond; Lodes, Michael J.; Reed, Steven G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds and methods for the diagnosis and treatment of Ehrlichia infection in particular human granulocytic ehrlichiosis are disclosed. The compounds , provided include polypeptides that contain at least one antigenic portion of an Ehrlichia antigen and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of Ehrlichia infection in patients and biological samples. Antibodies directed against such polypeptides are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 23, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 23, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 23, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.